Search All UT System Experts

Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy

Undiagnosed Diseases Network

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy'. Together they form a unique fingerprint.

Medicine & Life Sciences